Ralf Bannemerschult

No ORCID on file · 1 paper in corpus

article 2020

Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under

·doi:10.1080/13625187.2020.1731734

Women aged ≤25 and >25 years have a similar experience with an E2V/DNV oral contraceptive, supporting this as an appropriate contraceptive option in younger and older women.